Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Cetuximab × Sarcoma × Clear all

Phase

Status

Completed 5 Active not recruiting 3 Withdrawn 2 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 67 Head & Neck 41 Thoracic 10 Tumor-Agnostic 7 Gynecologic 4 CNS 4 Breast 2 Sarcoma 1 Plasma cell 1 Other solid neoplasm 1 Genitourinary 1 Dermatologic 1

Conditions

Sarcoma 1 Neoplasm Metastasis 1 Melanoma 1

Interventions

Cyclophosphamide 26 Temozolomide 23 Doxorubicin 22 Radiotherapy 21 Filgrastim 19 Ifosfamide 15 pazopanib 14 Gemcitabine 14 Etoposide 13 Irinotecan 12 Cisplatin 12 Bevacizumab 12 Magnetic Resonance Spectroscopy 11 Imatinib Mesylate 11 Granulocyte Colony-Stimulating Factor 11 Carboplatin 11 Radiation 9 Methotrexate 9 pembrolizumab 8 fludarabine phosphate 8 Rituximab 8 Paclitaxel 8 Docetaxel 8 Cyclosporine 8 Busulfan 8 Antilymphocyte Serum 8 fludarabine 7 Vincristine 7 Radiotherapy, Intensity-Modulated 7 Mycophenolic Acid 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03009058 2024-11-25

MODULATE

Immodulon Therapeutics Ltd

Phase 1/2 Terminated

2 enrolled 7 charts

DermatologicSarcoma

Melanoma, Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡